% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • jsblvbjb jsblvbjb Mar 28, 2013 8:39 AM Flag

    This is great news!!!

    Will Lewis had been trying to get orphan designation and failed, I suppose due to the handling of the rat study data. Arikace is in the driver's seat to capture the NTM market, and that's huge as not too much value has been given to Insmed based on this indication. So far, most value is in CF, but NTM is an even bigger indication! Good morning!

    Sentiment: Strong Buy

11.03-0.04(-0.36%)9:47 AMEDT